SCHEMBL4432486

SCHEMBL4432486

O=C(O)c1ccccc1OC(F)(F)C(F)C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.54
HSD17B10 Q99714 7/20 0.54
TSHR P16473 2/20 0.54
KDM4E B2RXH2 8/20 0.46
HPGD P15428 5/20 0.46
ESR1 P03372 1/20 0.45
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
HMGB1 P09429 1/20 0.45
GGT1 P19440 1/20 0.45
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
BLM P54132 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
RECQL P46063 2/20 0.44
MAPT P10636 3/20 0.44
USP2 O75604 2/20 0.44
PDE3A Q14432 1/20 0.44
KMT2A Q03164 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976982 0.88 KDM4E (0.50) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL9718890 0.86 TSHR (0.50) ALDH1A1HSD17B10TSHRRECQLMAPT
SCHEMBL3669236 0.86 IRAK4 (0.49) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL2940312 0.86 TSHR (0.45) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL7751671 0.80 ALDH1A1 (0.46) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL219675 0.79 KDM4E (0.53) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL29374906 0.79 KDM4E (0.53) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL11115857 0.79 HSD17B10 (0.49) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL5038454 0.77 KDM4E (0.51) ALDH1A1HSD17B10TSHRKDM4EHPGD
SCHEMBL4432803 0.77 KDM4E (0.51) ALDH1A1HSD17B10TSHRKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605163-B2 Benzoyl-piperazine derivatives HOFFMANN-LA ROCHE INC. (US) 2009-10-20 US disclosed
US-20080119486-A1 BENZOYL-PIPERAZINE DERIVATIVES JOLIDON SYNESE 2008-05-22 US disclosed
US-7319099-B2 Such as 1-{3-fluoro-4-[4-(2-isopropoxy-5-methanesulfonyl benzoyl)-piperazin-1-yl]-phenyl}-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease HOFFMANN-LA ROCHE INC. (US) 2008-01-15 US disclosed
US-20050209241-A1 Benzoyl-piperazine derivatives HOFFMANN-LA ROCHE INC. 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209241-A1 Benzoyl-piperazine derivatives SLC1A2, SLC18A2, SLC6A7 ALDH1A1 1436/4885HSD17B10 2913/4885TSHR 4739/4885
US-20080119486-A1 BENZOYL-PIPERAZINE DERIVATIVES SLC1A2, SLC18A2, SLC6A7 ALDH1A1 1436/4885HSD17B10 2913/4885TSHR 4739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.